Cargando…

Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts

BACKGROUND: Prospective studies have indicated that elevated blood glucose levels may be linked with increased cancer risk, but the strength of the association is unclear. We examined the association between blood glucose and cancer risk in a prospective study of six European cohorts. METHODS AND FI...

Descripción completa

Detalles Bibliográficos
Autores principales: Stocks, Tanja, Rapp, Kilian, Bjørge, Tone, Manjer, Jonas, Ulmer, Hanno, Selmer, Randi, Lukanova, Annekatrin, Johansen, Dorthe, Concin, Hans, Tretli, Steinar, Hallmans, Göran, Jonsson, Håkan, Stattin, Pär
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791167/
https://www.ncbi.nlm.nih.gov/pubmed/20027213
http://dx.doi.org/10.1371/journal.pmed.1000201
_version_ 1782175165625401344
author Stocks, Tanja
Rapp, Kilian
Bjørge, Tone
Manjer, Jonas
Ulmer, Hanno
Selmer, Randi
Lukanova, Annekatrin
Johansen, Dorthe
Concin, Hans
Tretli, Steinar
Hallmans, Göran
Jonsson, Håkan
Stattin, Pär
author_facet Stocks, Tanja
Rapp, Kilian
Bjørge, Tone
Manjer, Jonas
Ulmer, Hanno
Selmer, Randi
Lukanova, Annekatrin
Johansen, Dorthe
Concin, Hans
Tretli, Steinar
Hallmans, Göran
Jonsson, Håkan
Stattin, Pär
author_sort Stocks, Tanja
collection PubMed
description BACKGROUND: Prospective studies have indicated that elevated blood glucose levels may be linked with increased cancer risk, but the strength of the association is unclear. We examined the association between blood glucose and cancer risk in a prospective study of six European cohorts. METHODS AND FINDINGS: The Metabolic syndrome and Cancer project (Me-Can) includes cohorts from Norway, Austria, and Sweden; the current study included 274,126 men and 275,818 women. Mean age at baseline was 44.8 years and mean follow-up time was 10.4 years. Excluding the first year of follow-up, 18,621 men and 11,664 women were diagnosed with cancer, and 6,973 men and 3,088 women died of cancer. We used Cox regression models to calculate relative risk (RR) for glucose levels, and included adjustment for body mass index (BMI) and smoking status in the analyses. RRs were corrected for regression dilution ratio of glucose. RR (95% confidence interval) per 1 mmol/l increment of glucose for overall incident cancer was 1.05 (1.01–1.10) in men and 1.11 (1.05–1.16) in women, and corresponding RRs for fatal cancer were 1.15 (1.07–1.22) and 1.21 (1.11–1.33), respectively. Significant increases in risk among men were found for incident and fatal cancer of the liver, gallbladder, and respiratory tract, for incident thyroid cancer and multiple myeloma, and for fatal rectal cancer. In women, significant associations were found for incident and fatal cancer of the pancreas, for incident urinary bladder cancer, and for fatal cancer of the uterine corpus, cervix uteri, and stomach. CONCLUSIONS: Data from our study indicate that abnormal glucose metabolism, independent of BMI, is associated with an increased risk of cancer overall and at several cancer sites. Our data showed stronger associations among women than among men, and for fatal cancer compared to incident cancer. Please see later in the article for the Editors' Summary
format Text
id pubmed-2791167
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-27911672009-12-22 Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts Stocks, Tanja Rapp, Kilian Bjørge, Tone Manjer, Jonas Ulmer, Hanno Selmer, Randi Lukanova, Annekatrin Johansen, Dorthe Concin, Hans Tretli, Steinar Hallmans, Göran Jonsson, Håkan Stattin, Pär PLoS Med Research Article BACKGROUND: Prospective studies have indicated that elevated blood glucose levels may be linked with increased cancer risk, but the strength of the association is unclear. We examined the association between blood glucose and cancer risk in a prospective study of six European cohorts. METHODS AND FINDINGS: The Metabolic syndrome and Cancer project (Me-Can) includes cohorts from Norway, Austria, and Sweden; the current study included 274,126 men and 275,818 women. Mean age at baseline was 44.8 years and mean follow-up time was 10.4 years. Excluding the first year of follow-up, 18,621 men and 11,664 women were diagnosed with cancer, and 6,973 men and 3,088 women died of cancer. We used Cox regression models to calculate relative risk (RR) for glucose levels, and included adjustment for body mass index (BMI) and smoking status in the analyses. RRs were corrected for regression dilution ratio of glucose. RR (95% confidence interval) per 1 mmol/l increment of glucose for overall incident cancer was 1.05 (1.01–1.10) in men and 1.11 (1.05–1.16) in women, and corresponding RRs for fatal cancer were 1.15 (1.07–1.22) and 1.21 (1.11–1.33), respectively. Significant increases in risk among men were found for incident and fatal cancer of the liver, gallbladder, and respiratory tract, for incident thyroid cancer and multiple myeloma, and for fatal rectal cancer. In women, significant associations were found for incident and fatal cancer of the pancreas, for incident urinary bladder cancer, and for fatal cancer of the uterine corpus, cervix uteri, and stomach. CONCLUSIONS: Data from our study indicate that abnormal glucose metabolism, independent of BMI, is associated with an increased risk of cancer overall and at several cancer sites. Our data showed stronger associations among women than among men, and for fatal cancer compared to incident cancer. Please see later in the article for the Editors' Summary Public Library of Science 2009-12-22 /pmc/articles/PMC2791167/ /pubmed/20027213 http://dx.doi.org/10.1371/journal.pmed.1000201 Text en Stocks et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Stocks, Tanja
Rapp, Kilian
Bjørge, Tone
Manjer, Jonas
Ulmer, Hanno
Selmer, Randi
Lukanova, Annekatrin
Johansen, Dorthe
Concin, Hans
Tretli, Steinar
Hallmans, Göran
Jonsson, Håkan
Stattin, Pär
Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
title Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
title_full Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
title_fullStr Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
title_full_unstemmed Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
title_short Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
title_sort blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791167/
https://www.ncbi.nlm.nih.gov/pubmed/20027213
http://dx.doi.org/10.1371/journal.pmed.1000201
work_keys_str_mv AT stockstanja bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT rappkilian bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT bjørgetone bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT manjerjonas bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT ulmerhanno bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT selmerrandi bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT lukanovaannekatrin bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT johansendorthe bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT concinhans bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT tretlisteinar bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT hallmansgoran bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT jonssonhakan bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts
AT stattinpar bloodglucoseandriskofincidentandfatalcancerinthemetabolicsyndromeandcancerprojectmecananalysisofsixprospectivecohorts